Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.93

€2.93

-2.080%
-0.062
-2.080%
€31.90
 
09:31 / Tradegate WKN: A3CSM8 / Symbol: TPST / Name: Tempest Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Tempest Therapeutics Inc. Stock

A loss of -2.080% shows a downward development for Tempest Therapeutics Inc..
Tempest Therapeutics Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 31 € there is potential for a 959.47% increase which would mean more than doubling the current price of 2.93 € for Tempest Therapeutics Inc..
Our community identified positive and negative aspects for Tempest Therapeutics Inc. stock for the coming years. 7 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tempest Therapeutics Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.

Pros and Cons of Tempest Therapeutics Inc. in the next few years

Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

It seems that Tempest Therapeutics Inc. experienced a significant decline in its stock price today, which may have led to concerns among investors backpack battles
Show more

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for TPST provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -11.31%
Target price 43.325
Change
Ends at 20.03.25

Tempest Therapeutics, Inc. (NASDAQ: TPST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Ratings data for TPST provided by MarketBeat
Show more